Jordi Sanchez

Jordi Sanchez has extensive experience in the pharmaceutical industry, currently serving as CEO of Bayer Iberia and Country Division Head for Pharmaceuticals in Spain since July 2013. Previous roles at Bayer include various VP positions overseeing global marketing and product management in areas such as oncology, thrombosis, ophthalmology, and hematology. Prior to joining Bayer, Jordi Sanchez held several leadership positions at Amgen, including Executive Commercial Director for Iberia, managing P&L responsibilities across oncology and nephrology. Earlier career highlights include roles at Sanofi, AstraZeneca, and Almirall, focusing on clinical research and project management. Jordi Sanchez's educational background includes advanced degrees from IMD, IESE Business School, and multiple qualifications from Universitat Autònoma de Barcelona and Universitat de Barcelona in pharmacology, pharmaceutical medicine, and biochemistry.